ImaCor Hemodynamic Management
In This Issue
Extending the FAST Exam with hTEE
hTEE Evidence-Based Healthcare Economics for Trauma Patients
ImaCor hTEE in Trauma Patients - A Miniseries of Case Reports
Pellerito's Corner
____________________
 
Upcoming
hTEE logo
  Courses

Workshop Image
Hemodynamic Transesophageal Echo
Workshop

Other hTEE Course Dates:

March 17th Dallas, TX
May 19th  NY, NY
June 30th Chicago, IL

To Register or For More Information,
Please Contact

Geeta Surti
1.516.393.0970 or
courses@imacorinc.com
___________________

Trade Shows

We invite you to join us at the following trade shows: 

     Eastern Association for
         January 10-14, 2012
Lake Buena Vista, FL.
Table #9


 48th Annual Meeting: Society
of Thoracic Surgeons (STS)

January 29-31, 2012
Ft. Lauderdale, FL.
Booth #108


STS-AATS Tech Con
January 28-29, 2012
Ft.Lauderdale, FL.
Table #12


The Society of Critical Care
Medicine (SCCM)

February 4-8, 2012
Houston, TX. 
Booth #114.

We look forward to seeing you there!
EAST ad
___________________

Client Testimonial

"hTEE™ provides easily-acquired, clear images that we use to affirm or redirect our course of management, leading to optimal patient care

Dr. Benjamin Kohl, Chief, Division of Critical Care at the Hospital of the University of Pennsylvania
 
 
____________________

hTEE logo
Video for Trauma
Video link
hTEE for Trauma
 Scott Roth, MD FACC 
Co-Founder & CMO,
ImaCor Inc. 
Watch Now! 
Contact Us

 

imacorinc.com 

 

 

 
 
1-516-393-0970 
Introduction
Extending the FAST Exam With hTEE™ in Trauma by Harold Hastings PhD, Co-Founder and CTO of ImaCor Inc.  

  

The FAST  (Focused Assessment with Sonography in Trauma) exam (Rozycki and Shackford, J Trauma, 1996) made ultrasound the standard of care for assessing patients presenting with severe trauma.  "Considering the pace of the trauma setting, ultrasound is an ideal modality for assessment of these patients.  It should be the initial diagnostic test for the evaluation of patients with precordial wounds and blunt truncal injuries because it is rapid and accurate, and it augments the surgeon's diagnostic capabilties." (Rozycki and Newman, Adv Sug, 1999).  The ImaCor hTEE system, designed for ongoing management of hemodynamic instability in intensive care and cleared by the FDA to remain indwelling up to 72 hours, offers the trauma surgeon and intensivist another similarly focused assessment tool, aimed at ongoing assessment of cardiac function and volume status.

      

hTEE uses the focused exam by Vieillard-Baron et al. (Intensive Care Med 2004): "a long-axis view permits examination of the four cardiac cavities ... we measure left ventricular (LV) and right ventricular (RV) end-diastolic and end-systolic size and calculate the LV ejection fraction. . . . A short-axis view of both ventricles by a transgastric . . . approach also permits measurement of LV size, calculation of LV fractional area contraction, and examination of septal shape and kinetics. (Thirdly), a long-axis view of the superior vena cava, anastomosing with the right atrium, allows us to examine variation in its diameter during the respiratory cycle."

      

Here are static pictures of the above TEE views using the ImaCor hTEE system:

 Images from ImaCor system

Ecnomics Update
hTEE™ Evidence-Based Healthcare Economics for Trauma Patients (2nd in Series)   
...  The 2002 Zenati-Billiar study, published in the Journal of Trauma, shows how periods of hypotension adversely impact the length of stay of critically ill trauma patients. Using hTEE™ on Day 1 for patients with predicted ICU stays greater than 3 days, can significantly benefit the economics of trauma critical care by improving patient care
Zenati Billiar study
                                                                          Read More
Featured Clinical Case

ImaCor hTEE in Trauma Patients - A Miniseries of Case Reports

       

...The following case summaries illustrate a broad range of applications of hTEE in managing burn and trauma patients, from assessment of cardiac filling and function, guiding resuscitation (especially useful in the case of presumed sepsis), and guiding management of conflicting surgical requirements.

 

Case I. hTEE detects underfilling, rules out LV dysfunction. Donald Reiff, MD, and S. Chris Bellot, MD. University of Alabama at Birmingham, Birmingham, AL . . .     
Case II. hTEE guides resuscitation of patient with septic shock and ARDS post MVA. Benjamin Kohl, M.D., Hospital at the University of Pennsylvania, Philadelphia, PA . . .

Case III. hTEE reveals and guides resuscitation first for hypovolemic shock, later for sepsis in a severely burned patient. Donald Reiff, MD. University of Alabama at Birmingham, Birmingham, AL . . .

 Case IV. hTEE guides management of a trauma patient with right ventricular rupture. Benjamin Kohl, M.D., Hospital at the University of Pennsylvania, Philadelphia, PA . . .

                                                                          Read More 
January 1, 2012
 
I appreciate this opportunity to engage with you, and I thank you for your support.  Perhaps you are a customer at one of our premier sites, an advocate who espouses our revolutionary technology, or have expressed an interest in ImaCor over the past year.

The year 2011 was a momentous year for us at ImaCor.  We added 35 new systems, and participated in over 1,200 clinical cases.  We received our CE Mark in Europe during the summer, and will have ten luminary European sites installed by early 2012.  We began developing clinical pathways in education, and built a training program for our customers as they strive to better treat their patients.  Other key initiatives included architectural development of a clinical training pathway infrastructure that incorporates image interpretation modules, bedside hTEE imaging and a defined hTEE™ approach.  We also built out our clinical sales team in the United States, and developed our global and clinical segmentation.  ImaCor began addressing how TEE imaging was integrated perioperatively, worldwide.  Concomitantly, ImaCor realized a significant impact in helping to deliver better patient outcomes with our groundbreaking technology.

In 2012, we will continue to build our company with a key focus on Education, Clinical Research, Trauma and Perioperative Care.  Our CME
 and non-CME courses in 2011 proved to be quite successful and, in 2012, we are continuing with several new courses scheduled throughout the USA and Europe.  We are heavily invested in delivering ever-improving online modules to our current and new customers, normal and abnormal pathology reading rooms, and formalized training pathways for hTEE™ users.

As a company, we are focused on providing advanced solutions in critical care, and we never rest.  Our R&D team provided the world's first hTEE™ products.  Our R&D team now continues to deliver novel and innovative solutions in TEE imaging.  Look for new products as early as Spring of 2012.

Thank you again for your business, your continued support, and your loyal readership.  I welcome your candid feedback as we continue to introduce hTEE™ management worldwide.  Together, we can accomplish much in this dynamic frontier.

With best wishes for a happy and healthy new year,

Peter Pellerito
President & CEO 
Like us on FacebookView our profile on LinkedInFollow us on Twitter